Drug Database
Back to search

United States· US:62135-842_22e33608-9604-ec44-e063-6394a90a3d12

sulfADIAZINE

A sulfadiazine product containing sulfadiazine, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 8 of our 19 countries.

ATC J01EC02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedsulfADIAZINEATCJ01EC02REGISTER NO.US:62135-842_22e33608…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sulfadiazineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sulfadiazine is registered in 8 of 19 countries.

Countries holding a registration under ATC J01EC02 (sulfadiazine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search sulfadiazine products by name

Sulfadiazine · ATC J01EC02

8 / 19 countries

  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulfadiazine costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.18 in France to $0.72 in Spain — a ×4.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sulfadiazine · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • ES Spain$0.72
  • FR France$0.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SULFADIAZINE
Manufacturer
Chartwell RX, LLC
Country
United States (US)
ATC code
J01EC02
ATC class
Sulfadiazine
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    62135-842-60
  • ndc11
    6213584260
    60 TABLET in 1 BOTTLE (62135-842-60)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for sulfadiazine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sulfadiazine against other medicinesHow interaction checks work

Sulfadiazine · interactions on record

97 records

  • 5 severe
  • 61 moderate
  • 31 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • Aminobenzoic acidD02BA01severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sulfadiazine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulfadiazine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Sulfadiazin Heyl
  • Spain · Sulfadiazina Reig Jofre
  • France · Adiazine
  • United Kingdom (Northern Ireland) · Sulfadiazine Wockhardt Uk
  • Malta · Sulfadiazine Reig Jofre
  • Netherlands · Zilversulfadiazine Sandoz
  • Portugal · Labdiazina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/25e1db87-7528-43eb-bcb8-36eedac1f3c2
GET /v1/drugs/25e1db87-7528-43eb-bcb8-36eedac1f3c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "SULFADIAZINE",
  "productndc": "62135-842",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA080084",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about sulfadiazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console